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1015-9584/Copyright ª 2015, Asian SuSummary Introduction: To report our experience in palliative hepaticojejunostomy for
advanced malignant biliary obstruction by means of robotic approach
Methods: Robot-assisted laparoscopic hepaticojejunostomy for advanced malignant biliary
obstruction was performed in nine patients from May 2009 to April 2014.
Results: During the study period, robotic hepaticojejunostomy for advanced malignant biliary
obstruction was completed successfully in nine patients. Roux-en-Y hepaticojejunostomy and
double (hepaticojejunostomy, and gastrojejunostomy) bypass were performed in five and four
patients, respectively. The mean operating time was 212.8 minutes. The mean blood loss was
38.7 mL. The overall complication rate was 22.2%. Bile leak complication occurred in one pa-
tient only. There was no procedure-related mortality. The mean postoperative hospital stay
was 13.3 days. Five patients received palliative systemic chemotherapy after bypass surgery.
The mean survival time was 11.1 months. During follow up, only three patients with cholangio-
carcinoma had recurrent biliary obstruction after end-to-side hepaticojejunostomy due to tu-
mor progression, and needed percutaneous transhepatic biliary drainage. Among these nine
patients, there were a total of eight episodes of readmission in four patients due to tumor-
related symptoms or complications.
Conclusions: Robot-assisted laparoscopic hepaticojejunostomy for advanced malignant biliary
obstruction had a low complication rate and was associated with an improved quality of life.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.have no financial interests related to the material in the manuscript.
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Robotic palliative biliary bypass 2111. Introduction
Stenting of the biliary tree is a common palliative proce-
dure to relieve obstructive jaundice in advanced malig-
nancy. However, the methods adopted for palliation should
be able to provide optimum palliation and restoration of
quality of life with minimal physical trauma, low morbidity,
and rapid recovery. The minimally invasive approach of
surgical biliary bypass has these potential advantages.
Laparoscopic biliary bypass has the potential advantages of
earlier recovery, less postoperative pain, shorter hospital
stay, and better cosmetic outcome. However, laparoscopic
hepaticojejunostomy remains a surgical challenge, despite
the recent advances in minimally invasive surgical tech-
niques, because of its high degree of complexity.1,2 Its
application cannot be popularized. In an attempt to over-
come this limitation and to facilitate the difficult steps in
the minimally invasive surgery for hepaticojejunostomy,
robot-assisted laparoscopic hepaticojejunostomy may be a
solution. There are many special advantages of robotic
system, which overcome the obstacles of conventional
laparoscopic surgery.3 They improve visualization, restore
proper hand-eye coordination, increase dexterity, and an
ergonomic position. However, this technique and applica-
tion was rarely reported.
We report our experience in hepaticojejunostomy for
advanced malignancies by means of a robotic approach.
2. Materials and methods
Use of the robotic system for general surgery in our hospital
began in May 2009. The da Vinci S Surgical System (Intuitive
Surgical Inc., Sunnyvale, CA, USA) was used for all robot-
assisted procedures. Since then, a prospective database has
tracked all robot-assisted laparoscopic procedures. Be-
tween May 2009 and April 2014, nine consecutive patients
undergoing robot-assisted laparoscopic palliative hep-
aticojejunostomy for advanced malignancies were identi-
fied in our prospectively collected database. Their
demographics, pathology, perioperative outcomes, and
follow-up progress were recorded in the database. All op-
erations were performed by consultant surgeons with
experience in the conventional laparoscopic technique.
2.1. Operative technique
The patient is placed in a supine position with legs apart.
The patient is placed in a 20 reverse Trendelenburg posi-
tion. A 12-mm port was placed through a subumbilical
incision using a standard open technique. Then, one 12-mm
assistant port and three 8-mm robotic ports are inserted
under direct vision. An assistant port was used for passing
sutures, passing endostaplers, water irrigation, and doing
suction by the bedside surgeon. After staging laparoscopy
and laparoscopic ultrasound assessment, the robot system
is docked in.
The following procedure is similar to the open approach.
In order to prepare a Roux limb, a single jejunal Roux
limb approximately 60 cm from the ligament of Treitz is
selected and transected with endostaplers. The Roux limb
is brought up in an antecolic fashion for a tension-freehepaticojejunal anastomosis. For palliation of malignant
distal biliary strictures, a side-to-side sutured hep-
aticojejunal anastomosis is fashioned. For palliation of
more proximal malignant biliary strictures, an end-to-side
sutured hepaticojejunal anastomosis is fashioned after
transection of the bile duct. For a thin bile duct wall,
interrupted 3/0 Monocryl (Ethicon, Inc. Johnson and John-
son Company, Somerville, NJ, USA) sutures were used. For a
thickened bile duct wall, continuous 3/0 V-loc (Covidien,
Dublin, Ireland) sutures were used. Side-to-side jejunoje-
junostomy is fashioned at about 40 cm from the hep-
aticojejunal anastomosis. If a double gastric and biliary
bypass is to be performed, then the hepaticojejunal anas-
tomosis is performed first and the gastrojejunal anasto-
mosis second (Fig. 1AeC).
2.2. Statistical method
Continuous variables were expressed as mean  standard
deviation (SD) or range.
3. Results
During the study period, robot-assisted laparoscopic palli-
ative hepaticojejunostomy was completed successfully in
nine patients. Baseline characteristics of the patients are
shown in Table 1.
Roux-en-Y hepaticojejunostomy and double (hep-
aticojejunostomy and gastrojejunostomy) bypass was per-
formed in five and four patients, respectively. The mean
operating time was 212.8 minutes. The mean blood loss was
38.7 mL. The overall complication rate was 22.2%. Bile leak
complication occurred in one patient only. There was no
procedure-related mortality. The mean postoperative hos-
pital stay was 13.3 days. Five patients received palliative
systemic chemotherapy after bypass surgery. The mean
survival time was 11.1 months. During follow up, three
patients with cholangiocarcinoma over the common hepatic
duct (nZ 1), and mid-part of the common bile duct (nZ 2)
had recurrent biliary obstruction due to tumor progression
after end-to-side hepaticojejunostomy, and needed
percutaneous transhepatic biliary drainage. Among these
nine patients, there were just eight episodes of readmission
in four patients due to tumor-related symptoms or com-
plications (Table 1).
4. Discussion
The ideal palliative treatment for unresectable malig-
nancies that cause biliary obstruction should have a low
incidence of procedure-related complications and a long-
term relief of obstructive jaundice with minimal need for
reintervention. Surgical biliary bypass via the laparoscopic
approach is one of the feasible options. As with most
laparoscopic operations, laparoscopic palliative hep-
aticojejunostomy follows the same surgical principle as its
open counterpart, but with reduced physical trauma. The
potential advantages of laparoscopic palliative bypass sur-
gery for advanced malignancies are those of minimally
invasive surgery, such as earlier recovery, shorter hospital
Figure 1 (A) Port sites position (one subumbilical 12 mm camera port, three 8 mm ports for robotic arms, and one 12 mm as-
sistant port for bedside surgeon); (B) side-to-side hepaticojejunostomy was fashioned with interrupted 3/0 Monocryl (Ethicon, Inc.
Johnson and Johnson Company, Somerville, NJ, USA) sutures; (C) side-to-side jejunojejunostomy (Roux-en-Y reconstruction) was
fashioned with running 3/0 Monocryl (Ethicon, Inc. Johnson and Johnson Company) sutures.
212 E.C.H. Lai, C.N. Tangstay, and better cosmetic outcome. However, for the group
of patients with advanced malignancies, the surgical bypass
with earlier recovery can transform into a better chance of
receiving palliative systemic or local therapy, and having a
better quality of life. There was a low rate of anastomosis
occlusion and need for repeat procedures in patients
treated by surgical bypass.
Laparoscopic hepaticojejunostomy has been reported
but the experience remains limited, because laparoscopic
suturing requires advanced skills, requiring versatile, fine,
and precise movements to manipulate and suture tissue
within a confined space. The majority of reports were
concentrated on the pediatric group with choledochal
cysts. Conventional laparoscopic surgery has its own limi-
tations, including a reduced degree of freedom of move-
ment and a two-dimensional view instead of a three-
dimensional operative field, and poor ergonomics. These
limitations translate into a long learning curve, which re-
quires a lot of time and effort to acquire such advanced
laparoscopic skills. These limitations of conventional
laparoscopic surgery were the impetus behind the devel-
opment of robotic surgery. The robotic system appears
to provide some advantages to the surgeon. To our best
knowledge, human experiences of robotic hep-
aticojejunostomy have only been reported in pediatricgroups with choledochal cysts, and patients with recurrent
pyogenic cholangitis.4e9 Some of the experiences were
from robotic pancreaticoduodenostomy.10e12 Its applica-
tion as palliative bypass in advanced malignancy was re-
ported in an animal study only.13 Although the study
population was not large, the technique was safe, feasible,
and easy.
Our study evaluated the perioperative outcome and
follow-up results of robot-assisted laparoscopic Roux-en-Y
hepaticojejunostomy in patients with advanced malig-
nancy. To our best knowledge, this was the first reported
series in this area. The robotic system makes surgeries that
were technically difficult previously, now possible.
Although the current series was small, the robotic approach
was associated with a low complication rate, a low rein-
tervention rate, and a low readmission rate. These advan-
tages also allowed patients to receive palliative systemic
therapy in an earlier time, and to have less interruption due
to tumor-related complications during the course of palli-
ative systemic therapy. These also transformed into a
better quality of life.
In conclusion, robot-assisted laparoscopic hep-
aticojejunostomy for advanced malignant biliary obstruc-
tion had a low complication rate and was associated with an
improved quality of life.
Table 1 Patient characteristics, perioperative outcome, and follow-up.
Sex (male/female) (n) 5/4
Mean age (y) 71.6  10.5
Pathologies (n)
Ca head of pancreas 4
Ca ampulla 1
Cholangiocarcinoma 4
Causes of inoperability (n)
Metastases 4
Locally advanced with major vascular encasement or invasion 5
Operations (n)
Hepaticojejunostomy 5
Hepaticojejunostomy þ gastrojejunostomy 4
Mean operation time (min) 212.8  68.9 (SD)
Mean blood loss (mL) 38.7 (range, 3e50)
Overall complications (n) 2 (22.2%)
Intra-abdominal collection 0
Bile leak 1
Gastrojejunal anastomotic ulcer 1
Wound infection 0
Mean postoperative hospital stay (d) 13.3 (range, 5e53)
Recurrent gastric outlet obstruction during follow-up (n) 0
Recurrent biliary obstruction with PTBD insertion during follow-up (n) 3
Number of patients with readmission (n)
Anemia 1
Biliary obstruction 3
Total episodes of admission due to tumor-related symptoms or complications (n) 8
Mean overall survival (mo) 11.1  7.2
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